Events

Let’s Get Together

The biosimilars movement is a community dedicated to building a healthier tomorrow. Let’s come together to share ideas and resources to help increase patient access to biosimilars today.

Events for Everyone

Biosimilar medicines have the power to help patients treat serious diseases at a fraction of the cost of brand-name biologics. To raise awareness of biosimilars and bring down barriers, biosimilar advocates, scientists, patients and government officials must join together to find solutions.

The Association for Accessible Medicines (AAM) and its Biosimilars Council are proud to host events to promote biosimilars, and are equally proud to participate in events that others hold. Scroll down to see events that you can participate in to help biosimilar reach their full potential.

Access! 2023

February 13-15, 2023 | Orlando, Florida

Access! is the Association for Accessible Medicines’ annual conference bringing together the top minds in the generic and biosimilars industry. In a multi-day event, you can hear from industry leaders and government representatives about the state of the industry, network with your peers, feature your company at the expo and more. This year AAM will be hosting IGBA’s 25th Annual Conference on February 15-16 at the same hotel.

25th IGBA Conference

February 15-16, 2023 | Orlando, FL

The Association for Accessible Medicines (AAM) is hosting IGBA’s annual conference along with Access! 2023. This event will bring together top advocates in the generics and biosimilars industries from around the world. Sign up by December 16th for $100 off your full pass registration.

IGBA Global Biosimilars Week

March 20-23, 2023 | San Diego, CA

This year, AAM and its Biosimilars Council are official partners of the Festival of Biologics! This event, held in San Diego, California, gives you the opportunity to share research, create new partnerships, and tackle the clinical trials, manufacturing and commercial challenges involved in bringing new therapies to market. Register now!

GRx+Biosims Conference 

November 7-9, 2022 | North Bethesda, MD

GRx+Biosims is the premier scientific and regulatory event for the biosimilars and generics industry. Top officials and subject-matter experts share their knowledge and best practices to enhance attendees’ understanding of how to succeed in generic and biosimilar development, regulatory process and approvals, and the evolving policy landscape.

GRx+Biosims Conference 

November 7-9
North Bethesda, MD

GRx+Biosims is the premier scientific and regulatory event for the biosimilars and generics industry. Join us in person in North Bethesda, MD to hear from leading industry and government representatives, share your ideas and help build the biosimilars movement.

Other Events

IGBA Global Biosimilars Week

  • Each year, the Biosimilars Council invites biosimilars advocates from around the world to share their resources and stories on social media.

Women in Health Policy

  • AAM and the Biosimilars Council regularly host events featuring leading women specializing in health policy and biosimilar medicines. Join the LinkedIn Group for updates.

Festival of Biologics

  • Our Executive Director Craig Burton joined the keynote discussion at the 2022 Festival of Biologics to analyze the biosimilars market and its future.

Reuters Events: Unlock the potential of biosimilars: Improve patient access and long-term healthcare system sustainability

  • Former Executive Director Christine Simmon spoke about the need for policies that promote sustainable.

Related News and Blogs

People at GRx+Biosims

GRx+Biosims 2022 Conference Recap

Earlier this month, AAM and the Biosimilars Council hosted guests in North Bethesda, Maryland for the 2022 GRx+Biosims Conference. This... Read more »

Access! 2022 Conference Recap

February 14-16, AAM and its Biosimilars Council welcomed attendees to Orlando, Florida for Access! 2022, the generics and biosimilars industry’s... Read more »

GRx+Biosims 2021 Conference Recap

AAM’s 2021 GRx+Biosims conference has officially come to a close, and by all accounts it delivered on its promise to... Read more »
grx+biosims 2020

GRx+Biosims 2020 Conference Wrap-Up Blog

We’ve just completed this year’s GRx+Biosims 2020, the premier scientific and regulatory event for the U.S. generics and biosimilars industries,... Read more »

GRx+Biosims 2019 Conference: Advancing Biosimilars Access

Earlier this month the Association for Accessible Medicines (AAM) and its Biosimilars Council hosted the second annual GRx+Biosims Conference for... Read more »
GRx+Biosims 2019

Biosimilars Council Kicks Off GRx+Biosims 2019

The Association for Accessible Medicines (AAM) and its Biosimilars Council are eager for the start of this year’s GRx+Biosims conference... Read more »
Biosimilars Council - Renegotiated NAFTA Event

Patient Access to Affordable Medicines: How a Renegotiated NAFTA Could Keep Drug Prices High

Friday, September 14, 2018 Noon–1:00 p.m. 1310 Longworth House Office Building Committee on House Administration Hearing Room On August 31,... Read more »
The Biosimilars Council - Seniors Sitting at a Meeting

Breaking Through on Biosimilars: Delivering More-Affordable, Innovative Medicines for America’s Patients

Please join us on Thursday, July 26th at noon for a lunch briefing hosted by the Association for Accessible Medicines (AAM)... Read more »
The Biosimilars Council - GRxBiosims Event Banner

GRx+Biosims Conference

AAM listened to our members and conference attendees and has created the ultimate event for the industry. We combined all... Read more »
The Biosimilars Council - People Meeting Image

AAM Women in Health Policy Happy Hour

Thursday, April 19, 2018 – 5-7pm – 601 New Jersey Ave. NW Join The Biosimilars Council and the Association for... Read more »
The Biosimilars Council - Doctors Applauding

Leading on Biosimilars: 2017 AAM Biosimilars Council Conference Preview

Join us as we examine the promise of biosimilars in the United States and discuss how best to ensure patient... Read more »

The Next Drugs: An Atlantic Policy Briefing on Biosimilars

Underwritten by The Biosimilars Council The Atlantic gathered key stakeholders to examine the emerging world of biosimilars and their regulatory framework in the United States. How does the Food and Drug Administration implement[…]

The Next Drugs: The Future for Biosimilars, An Atlantic Policy Briefing

Join The Atlantic as we gather key stakeholders to examine the future for biosimilars domestically and abroad. What impact will... Read more »

Recent Tweets